Literature DB >> 8427381

Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys.

D E Kyle1, W K Milhous, R N Rossan.   

Abstract

An Aotus-Plasmodium falciparum model was used to determine if chloroquine resistance could be reversed in vivo. The putative resistance modulators tested all reverse chloroquine resistance in vitro and included verapamil, chlorpromazine, prochlorperazine, cyproheptadine, ketotifen, a tiapamil analog (Ro 11-2933), and a chlorpromazine analog (SKF 2133-A). Combinations of chloroquine plus chlorpromazine or prochlorperazine confirmed reversal of chloroquine resistance as exhibited by cures obtained in six Aotus monkeys infected with chloroquine-resistant P. falciparum (Vietnam Smith/RE strain) and rapid clearance of parasitemia, followed by recrudescence in six additional monkeys. The results indicate the following order of in vivo efficacy for reversing chloroquine resistance in Aotus: chlorpromazine > prochlorperazine >> desipramine >> Ro 11-2933 (tiapamil analog) > ketotifen. Cyproheptadine and verapamil were not effective in reversing chloroquine resistance and probable drug toxicity was observed with these drugs in combination with chloroquine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8427381     DOI: 10.4269/ajtmh.1993.48.126

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Ketotifen is an antimalarial prodrug of norketotifen with blood schizonticidal and liver-stage efficacy.

Authors:  Erin Milner; Jason Sousa; Brandon Pybus; Jennifer Auschwitz; Diana Caridha; Sean Gardner; Kristina Grauer; Erin Harris; Mark Hickman; Michael P Kozar; Patricia Lee; Susan Leed; Qigui Li; Victor Melendez; Jay Moon; Franklyn Ngundam; Michael O'Neil; Sandi Parriott; Brittney Potter; Rick Sciotti; Anchalee Tangteung; Geoffrey S Dow
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-03       Impact factor: 2.441

2.  Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.

Authors:  Jing Yuan; Ken Chih-Chien Cheng; Ronald L Johnson; Ruili Huang; Sittiporn Pattaradilokrat; Anna Liu; Rajarshi Guha; David A Fidock; James Inglese; Thomas E Wellems; Christopher P Austin; Xin-zhuan Su
Journal:  Science       Date:  2011-08-05       Impact factor: 47.728

3.  Potent enhancement of the sensitivity of Plasmodium falciparum to chloroquine by the bisbenzylisoquinoline alkaloid cepharanthin.

Authors:  K Haruki; P G Bray; M Ono; S A Ward
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Reversal of Chloroquine Resistance of Plasmodium vivax in Aotus Monkeys.

Authors:  Nicanor Obaldia; Wilbur K Milhous; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

5.  Chlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT.

Authors:  Karen J Deane; Robert L Summers; Adele M Lehane; Rowena E Martin; Russell A Barrow
Journal:  ACS Med Chem Lett       Date:  2014-03-03       Impact factor: 4.345

6.  Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials.

Authors:  P Loria; S Miller; M Foley; L Tilley
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

7.  Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.

Authors:  Fabián E Sáenz; Tina Mutka; Kenneth Udenze; Ayoade M J Oduola; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2012-06-18       Impact factor: 5.191

8.  In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine.

Authors:  Marcus R Pereira; Philipp P Henrich; Amar Bir Singh Sidhu; David Johnson; Joel Hardink; Jeffrey Van Deusen; Jian Lin; Katrina Gore; Connor O'Brien; Mamadou Wele; Abdoulaye Djimde; Richa Chandra; David A Fidock
Journal:  Antimicrob Agents Chemother       Date:  2011-04-04       Impact factor: 5.191

9.  Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.

Authors:  Svenja Meierjohann; Rolf D Walter; Sylke Müller
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

10.  A class of tricyclic compounds blocking malaria parasite oocyst development and transmission.

Authors:  Richard T Eastman; Sittiporn Pattaradilokrat; Dipak K Raj; Saurabh Dixit; Bingbing Deng; Kazutoyo Miura; Jing Yuan; Takeshi Q Tanaka; Ronald L Johnson; Hongying Jiang; Ruili Huang; Kim C Williamson; Lynn E Lambert; Carole Long; Christopher P Austin; Yimin Wu; Xin-Zhuan Su
Journal:  Antimicrob Agents Chemother       Date:  2012-11-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.